Navigation Links
Randomize Gene Sequences with New PCR Mutagenesis Kit

GeneMorph PCR mutagenesis kit produces a unique mutational spectrum

Janice Cline Holly Hogrefe


The GeneMorph PCR mutagenesis kit simplifies the process of constructing mutant libraries for protein evolution and structure-function studies. Errors are introduced during PCR at low, moderate, or high mutation frequencies using a single set of optimal reaction conditions. The kit features Mutazyme DNA polymerase, a novel error-prone DNA polymerase mutant developed at Stratagene. Mutazyme DNA polymerase produces all possible transition and transversion mutations with minimal bias, and its mutational spectrum is distinct from that of Taq DNA polymerase. Unlike current Taq- based protocols, the GeneMorph method is robust and can be applied to mutagenesis of long targets (1-10 kb).

Error-prone PCR is a random mutagenesis technique for introducing amino acid changes into proteins. Mutations are deliberately introduced during PCR through the use of error-prone DNA polymerases and reaction conditions.1,2 Randomized DNA sequences are cloned into expression vectors, and the resulting mutant libraries are screened for altered or improved protein activity. To analyze structure-function relationships, mutation frequencies of one amino acid change (1-2 nucleotide changes) per gene are desired, while directed evolution studies typically empl

Quantitating PCR product yield: PCR products (10 ml) were electrophoresed on 1% agarose gels along side the 1-kb double-stranded DNA standard provided in the kit. PCR product yields were quantified using the Eagle Eye II still video system as described in the manual for the GeneMorph PCR mutagenesis kit.

lacZ mutagenesis assay: A 650-bp product, containing a 300-bp fragment of lacZ, was amplified from a chloramphenicol resistant lacZ/pBC SK+ plasmid construct. The PCR primers were designed to introduce LIC (ligation independent cloning) sequences at the 5 and 3 ends of the insert. The PCR products were gel purified using the StrataPrep gel extraction kit and then cloned into the Affinity LIC vector as described in the cloning kit manual. SoloPack competent cells were transformed and plated on ampicillin/LB plates. lacZ mutants were scored in a color screening assay by plating transformants on Xgal/IPTG/amp plates. Percent lacZ mutants was calculated as the number of colorless colonies (mutants lacking bgalactosidase activity) divided by the total number of colonies plated (blue plus colorless colonies).

DNA sequencing: Mutation frequencies and mutational spectra were analyzed by DNA sequencing. Individual colonies were randomly selected and resuspended in 200 ml of TE. One ml of each suspension was amplified with Herculase enhanced DNA polymerase using a gene-specific primer and a vector-specific primer. PCR products were purified using the StrataPrep PCR purification kit, and DNA sequencing was performed using a nested gene-specific primer (Sequetech).


1. Leung, D.W., et al. (1989) Technique 1: 11-15.
2. Cadwell, R.C. and Joyce, G.F. (1992) PCR Methods Appl. 2: 28-33.
3. Shafikhani, S., et al. (1997) Biotechniques 23: 304-310.
4. Wan, L., et al. (1998) Proc. Natl. Acad. Sci. U.S.A. 95: 12825-12831
5. You, L. and Arnold, F.H. (1996) Protein Eng. 9: 77-83.
6. Cherry, J.R. et al. (1999) Nat. Biotechnol. 17: 379-384.
7. Daugherty, P.S., et al. (2000) Proc. Natl. Acad. Sci. U.S.A. 97: 2029-2034.
8. Vartanian, J.P., et al. (1996) Nucleic Acids Res. 24: 2627-2631.
9. Ling, L.L. et al. (1991) PCR Meth. Appl.1: 63-69.
10. Eckert, K. and Kunkel, T.A. (1990) Nuc. Acids Res. 18: 3739-3744.

See page 168.

oy mutation frequencies of one to four amino acid changes (2-7 nucleotide changes) per gene.3-6 Proteins with improved activities have also been isolated from highly mutagenized libraries exhibiting 20 point mutations per gene.7 Error-prone PCR methods commonly employ Taq DNA polymerase, as it lacks proofreading activity. To achieve useful mutation frequencies, the error rate of Taq DNA polymerase is further increased by employing PCR reaction buffers containing Mn2+ and unbalanced dNTP concentrations.1,2, These changes, however, can lead to lower PCR product yields4 and a strong bias in the types of mutations produced (mutational spectra). 2

The GeneMorph PCR mutagenesis kit overcomes the limitations of Taq-based random mutagenesis methods by using an inherently error-prone PCR enzyme and varying DNA template concentration to achieve the desired mutation frequency.

Mutazyme DNA Polymerase


A key component of the GeneMorph kit is Mutazyme DNA polymerase, a novel DNA polymerase mutant developed at Stratagene. As shown in Figure 1, Mutazyme DNA polymerase introduces mutations much more frequently than Taq DNA polymerase. Moreover, high mutation frequencies are achieved under optimal PCR reaction conditions for the enzyme (MgCl2, balanced nucleotides). Despite its inherent high error rate, Mutazyme DNA polymerase produces high PCR product yields over a broad range of DNA template concentrations.

PCR Mutation Frequency


Mutation frequency (mutations/kb) is the product of DNA polymerase error rate and number of target duplications (Figure 2). In the GeneMorph kit, a sufficiently high error rate is achieved through use of Mutazyme DNA polymerase. Low, medium, or high mutation frequencies are obtained simply by varying the initial target DNA concentration in the PCR reaction. For the same PCR yield, targets amplified from low amounts of target DNA undergo more duplications than targets amplified from high concentrations of DNA. This principle is illustrated in Figure 3, which shows the number of times an amplicon is copied to produce theoretical yields of 0.5 mg or 10 mg. The more times a target is replicated, the more errors accumulate. Therefore, higher mutation frequencies are achieved simply by lowering input DNA template concentration. Conversely, lower PCR mutation frequencies can be achieved by using higher DNA template concentrations or fewer PCR cycles to limit the number of target duplications.


Selecting the Mutation Frequency of GeneMorph Reactions

Table I presents the initial amount of target DNA required to produce the desired mutation frequency using the GeneMorph kit. For simplicity, we divided the range of mutation frequencies produced by Mutazyme DNA polymerase into three different levels: low (0-3 mutations/kb), medium (3-8 mutations/kb), and high (>8 mutations/kb). Reactions employing 10 ng to 100 ng of target DNA produced mutation frequencies up to three mutations per kb (0.3%), while PC Rs carried out with 10 pg to 1 ng of DNA template introduced errors at a rate of three to seven mutations per kb (0.3%-0.7%). Mutation frequencies greater than 0.7% are achieved by performing sequential amplifications. By reamplifying a small portion of a PCR reaction, the number of target doublings can be substantially increased. Mutation frequencies of 0.6% to 1.3% or 0.9% to1.8% were produced by performing two or three sequential PCR reactions, respectively. (Table 1)

Random Mutagenesis of Target Genes


The efficiency and ease of use of the GeneMorph kit was demonstrated in studies employing lacZ as the mutational target gene. A 650-bp DNA fragment containing a portion of the lacZ gene was amplified with Mutazyme DNA polymerase from varying amounts of plasmid DNA (Figure 4). In this study, the PCR primers were designed to introduce LIC (ligation independent cloning) sites for cloning into the Affinity LIC vector. Mutazyme produced high yields of the 650-bp amplicon from 10 pg up to 100 ng of DNA template (Figure 4). Product yields were quantified by comparison to a DNA standard, and total yields ranged from 1 mg to 7.5 mg per 50-ml PCR reaction. In addition, a small portion of one reaction (Figure 4, Lane 5) was reamplified in two or three sequential PCR reactions (Figure 4, Lanes 8 and 9).

The frequency of mutations in the lacZ gene was determined for numerous PCR reactions employing various concentrations of DNA template. PCR products were gel purified and cloned into the Affinity vector (Methods). For each PCR reaction, 2 to 10 clones were randomly selected and sequenced. Fig ure 5 shows a plot of mutation frequency (number of mutations per kb) as a function of target duplication number. As expected, mutation frequency increased with decreasing template concentration (increasing d value). For the lacZ gene, low mutation frequencies (0.08%-0.3%) were produced in PCRs employing 10 ng to 100 ng DNA template (d=5.6-9.4). PCRs performed with 10 pg, 100 pg, or 1 ng of DNA template (d=12.3-19.6) exhibited mutation frequencies ranging from 0.3% to 0.8%, while the highest mutation rates were achieved in reactions employing two (0.7%-1.4%; d=30-34) or three (1.6%; d=49) sequential PCRs.


The GeneMorph kit has been used to mutagenize other target genes, including a 2.5-kb polymerase gene and a 720-bp sequence encoding Green Fluorescent Protein (GFP). (Figure 5)

Mutational Spectrum of Mutazyme

Table 2 shows the types of mutations introduced by Mutazyme DNA polymerase. These data were compiled from DNA sequence analysis (37.5-kb total) of 45 clones randomly selected from lacZ mutagenesis studies. Mutations were distributed uniformly throughout the lacZ gene, rather than localized in hotspots (data not shown). Mutazyme DNA polymerase introduced all possible transition (purinepurine; pyrimidinepyrimidine) and transversion (purinepyrimidine; pyrimidinepurine) mutations, while insertions and deletions were relatively rare (~1%).

Mutational bias is most commonly analyzed by calculating either the ratio of transition (Ts) to transversion (Tv) mutations or the ratio of AT to GC changes (ATGC/GCAT). Since there are eight possible t ransversions and four possible transitions, a DNA polymerase completely lacking bias would exhibit a Ts/Tv ratio of 0.5. Mutazyme DNA polymerase produces a Ts/Tv ratio of 1.2, indicating that the enzyme preferentially introduces transition mutations. In addition, Mutazyme exhibits a ATGC/GCAT ratio of 0.2, denoting a tendency to replace G or C with A or T. In comparison, an enzyme that lacks bias would produce an ATGC/GCAT ratio of 1.0. Similar Ts/Tv and ATGC/GCAT ratios were determined in limited mutagenesis studies employing the polymerase and GFP genes (data not shown).

GeneMorph Kit Produces a Unique Mutational Spectrum

In the GeneMorph kit, low, medium, and high mutation frequencies are achieved using a single set of optimal reaction conditions (MgCl2, balanced dNTPs). The only parameter varied is DNA template concentration. Therefore, the same spectrum of mutations is produced over a broad range of mutation frequencies (<0.1% to 0.7% per PCR). In contrast, Taq-based error-prone PCR methods typically employ different sets of reaction conditions to vary mutation levels.1-3,9,10 The particular conditions employed (Mn2+ or dNTP ratios) can influence the types of mutations produced.2,9,10

The mutational spectrum of Mutazyme DNA polymerase was compared to the spectra of mutations generated by Taq under typical error-prone conditions (0.5 mM MnCl2; 0.2 mM dATP/dGTP; 1 mM dCTP/TTP).2,3 In one published study,3 different mutation levels (0.1% -0.5% per PCR) were achieved by performing sequential PCRs and varying the MnCl2 concentration. Under these conditions, Taq preferentially introduces AT, TA, AG, and TC mutations (66%-68% of total mutations) and rarely incorporates GC and CG transversions. In comparison, Mutazyme DNA polymerase tends to produce GA, CT, GT, and CA changes (64% total mutations), and all transversion mutations are represented. Taq is approximately three times more likely to mutate As and Ts than Gs and Cs (ATGC/GCAT ratio >12,3), while Mutazyme DNA polymerase is nearly three times more likely to mutate Gs and Cs (ATGC/GCAT ratio 0.2). Both enzymes prefer to incorporate transition mutations rather than transversion mutations (Ts/Tv = 0.8-1.2) (Table 2).

As shown in Table 2, Mutazyme DNA polymerase produces a broad and unique spectrum of mutations, thereby facilitating the production of representative mutant libraries. The distinct mutational spectra of Mutazyme and Taq DNA polymerases implies that different types of mutations will be present in mutant libraries constructed by these different error-prone methods. For example, the GeneMorph kit facilitates mutagenesis of GC-rich targets and synthesis of GCCG transversions, both of which are relatively difficult for Taq DNA polymerase. Since mutation levels are varied without altering reaction conditions, the broad spectrum of mutations produced by the GeneMorph kit is maintained over a wide range of mutation frequencies, even at high mutation levels (6-13 mutations per kb/2 PCRs). In contrast, to achieve high mutation frequencies with Taq (>4.9-6.6 mutations per kb2,3), it is typical to increase the dGTP concentration (final conditions: 0.5 mM MnCl2; 0.2 mM dATP; 1 mM dCTP /TTP/dGTP), which leads to significant bias in Taqs mutational spectrum (Ts/Tv ratio, 2.7; ATGC/GCAT ratio, 10).1,2

GeneMorph Kit Provides Superior Yields

The GeneMorph kit must employ a robust PCR enzyme to ensure high product yield from low DNA template concentrations (highly mutagenic conditions). Since Mutazyme DNA polymerase is inherently error prone, high mutation frequencies are achieved using optimal PCR reaction conditions. In contrast, employing Mn2+ and unbalanced dNTP pools to lower the fidelity of Taq leads to reduced product yield,8 and such conditions are generally only useful for amplifying targets up to 1 kb in length.1

The superior performance of Mutazyme DNA polymerase is demonstrated in Figure 6. A series of targets, 0.65 kb to 10 kb in length, were amplified under error-prone conditions using Mutazyme and Taq DNA polymerases. For Taq reactions, the error-prone reaction conditions were employed,2 except that the MgCl2 concentration was decreased from 7 mM to 1.5 mM. PCRs were performed using identical cycling conditions and DNA template concentrations. Mutazyme DNA polymerase (2.5 U) produced high yields of all amplicons, while Taq DNA polymerase (5 U) successfully amplified only the shortest 650-bp product (Figure 6). The 650-bp product was not successfully amplified using 2.5 U Taq DNA polymerase or buffers containing 7 mM MgCl2, as recommended2 (data not shown).



Stratagenes GeneMorph PCR Mutagenesis kit is a superior alternative to Taq-based random mutagenesis methods. The benefits of this kit include the unique characteristics of the error-prone Mutazyme DNA polymerase, synthesis of high product yields over a broad range of amplicon sizes (0.1-10 kb), efficient mutagenesis rates of one to seven bases per kb per PCR, incorporation of all mutation types with minimal bias, and a simplified protocol with one set of robust reaction conditions. The GeneMorph kit is a finely tuned system for achieving desired mutation frequencies and, producing a unique spectrum of mutations.


Error-prone PCR conditions: DNA sequences were amplified as described in the manual for the GeneMorph PCR mutagenesis kit. Briefly, an amount of plasmid DNA corresponding to 1 pg to 100 ng of amplicon was amplified in PCR reactions (50 ml) containing 1X Mutazyme reaction buffer, 200 mM each dNTP, 125 ng of each primer, and 2.5 U Mutazyme DNA polymerase. PCR reactions were performed with Taq DNA polymerase using identical conditions, except that 1X Taq reaction buffer (1.5 mM MgCl2) was employed. Error-prone PCR reactions contained 5 U of Taq DNA polymerase, 1X Taq reaction buffer (supplemented with 0.5 mM MnCl2), and a nucleotide mixture of 200 mM dGTP, 200 mM dATP, 1 mM dCTP, and 1 mM TTP.2

Sequential PCR amplifications: To obtain high mutation levels (>0.7%), PCR products were reamplified in a second PCR reaction. A small portion of a PCR reaction (e.g., amplicon synthesized from 0.1 ng-1 ng of DNA target) was first diluted 1:1000 in TE buffer. One ml of diluted amplicon was then reamplified as described above.



Page: All 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. New Yeast Cloning System for Producing Proteins with Native Amino Acid Sequences
2. Selecting siRNA Sequences to Incorporate into the pSilencer Vectors
3. Big Blue Rodent Cell Cultures for Mutagenesis Studies
4. High-Efficiency Site-Directed Mutagenesis of Large Plasmid Vectors
Post Your Comments:

(Date:6/28/2017)... PHILADELPHIA , June 28, 2017 ... Pediatrics at Georgetown University School of Medicine, and Founder, ... author of a study that has helped clarify the ... disease (PD) and other neurodegenerative diseases. Denise Barbut ... of Enterin Inc. was senior co-author of the study. ...
(Date:6/28/2017)... 2017 (PRWEB) , ... June ... ... of Siemens’ STAR-CCM+® software for multiphysics computational fluid dynamics (CFD) simulation and ... exploration and optimization. STAR-CCM+ version 12.04 introduces Design Manager, allowing users to ...
(Date:6/27/2017)... ... 2017 , ... Brain State Technologies, a leading neurotechnology company, ... 15th to fund production of the new B2v2 wearable brainwave balancing headband. Over ... more than 150% in a little over a week. , Utilizing Brain State’s ...
(Date:6/27/2017)... ... June 27, 2017 , ... DuPont Pioneer (DuPont) and ERS ... the ERS patent portfolio covering CRISPR-Cas genome editing technology for all agricultural uses ... (IP) of the CRISPR-Cas technology from co-inventor and co-owner Emmanuelle Charpentier, Ph.D. ...
Breaking Biology Technology:
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) is ... tech event dedicated to developing collaboration between startups and global ... June 15-17. During the event, nine startups will showcase the ... in various industries. France ... international market, with a 30 percent increase in the number ...
(Date:5/16/2017)... May 16, 2017   Bridge Patient Portal ... and MD EMR Systems , an electronic ... for GE, have established a partnership to build ... and the GE Centricity™ products, including Centricity Practice ... These new integrations will allow healthcare ...
(Date:4/19/2017)... April 19, 2017 The global ... landscape is marked by the presence of several large ... held by five major players - 3M Cogent, NEC ... accounted for nearly 61% of the global military biometric ... in the global military biometrics market boast global presence, ...
Breaking Biology News(10 mins):